Pirenzepine

growth hormone 1 ; Homo sapiens







24 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 10435880 Effects of cholinergic muscarinic blockade on growth hormone responses to growth hormone-releasing hormone in uraemic patients. 1999 Jul 1
2 8739115 Aspects of the neuroendocrine control of somatotropic function in calorically restricted dogs and patients with eating disorders: studies with cholinergic drugs. 1996 Apr 16 1
3 8834976 Reduced growth hormone secretion improves insulin sensitivity in adolescent girls with type 1 diabetes. 1996 Jan 4
4 7880938 Arginine but not pyridostigmine, a cholinesterase inhibitor, enhances the GHRH-induced GH rise in patients with anorexia nervosa. 1994 Nov 15 1
5 7923820 Radiation and neuroregulatory control of growth hormone secretion. 1994 Aug 2
6 8005563 Pirenzepine decreases basal and stimulated GH secretion in patients with type 2 (non-insulin-dependent) diabetes mellitus. 1994 Mar 3
7 8176181 [Inhibition of growth hormone in insulin-dependent diabetics after oral administration of pirenzepine. Fluorophotometric study of the vitreous body]. 1994 2
8 8181260 Modulation of glucose and growth hormone responses to meals and exercise in type 1 diabetes by cholinergic muscarinic blockade. 1994 Jan-Feb 1
9 8094648 Cholinergic control of growth hormone (GH) responses to GH-releasing hormone in insulin dependent diabetics: evidence for attenuated hypothalamic somatostatinergic tone and decreased GH autofeedback. 1993 Feb 3
10 8359093 Evidence for a role for insulin and growth hormone in overnight regulation of 3-hydroxybutyrate in normal and diabetic adolescents. 1993 Jul 1
11 8435890 The frequency and amplitude of growth hormone secretory episodes as determined by deconvolution analysis are increased in adolescents with insulin dependent diabetes mellitus and are unaffected by short-term euglycaemia. 1993 Jan 2
12 1454656 [Inhibition of growth hormone (GH) response to GHRH in diabetes mellitus type 1 after blockade of the cholinergic system with pirenzepine]. 1992 Jul 2
13 1723835 Impact of increased growth hormone secretion on carbohydrate metabolism in adolescents with diabetes. 1991 2
14 1908328 Blockade of cholinergic muscarinic receptors by pirenzepine and GHRH-induced GH secretion in the acute and recovery phase of anorexia nervosa and atypical eating disorders. 1991 Jun 1 2
15 1983729 Cholinergic modulation of growth hormone-releasing hormone effects on growth hormone secretion in dementia. 1990-1991 1
16 2106528 Effect of cholinergic muscarinic receptor blockade on human growth hormone (GH)-releasing hormone-(1-44)-induced GH secretion in anorexia nervosa. 1990 Mar 2
17 2114512 Reduced sensitivity to pirenzepine-induced blockade of growth hormone responses to arginine, exercise, and growth hormone-releasing hormone in type I diabetic subjects. 1990 Jul 4
18 2460722 The effect of cholinergic blockade on the growth hormone response to galanin in humans. 1988 Nov 1
19 3289300 The effect of pirenzepine on growth hormone and blood glucose levels in type I diabetes mellitus. A controlled study in patients on basal bolus insulin treatment. 1988 Mar 1
20 2882435 Dopaminergic and cholinergic influences on the growth hormone response to growth hormone-releasing hormone in man. 1987 Mar 2
21 3116574 Pirenzepine inhibits growth hormone, but not thyrotropin response to thyrotropin-releasing hormone in patients with endogenous depression. 1987 1
22 3755791 Differences in cardiac but not in neuroendocrine responses in healthy volunteers after administration of two antimuscarinic agents, atropine and pirenzepine. 1986 Sep 1 2
23 6434584 Blockade of hp-GRF-40-induced GH release in normal men by a cholinergic muscarinic antagonist. 1984 Nov 1
24 6549208 Effect of pirenzepine on apomorphine-induced growth hormone secretion in man. 1984 Jul-Sep 1